Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Cytek Biosciences (CTKB) over the last 5 years, with Q3 2025 value amounting to 0.08%.

  • Cytek Biosciences' Return on Capital Employed fell 200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.05% for FY2024, which is 100.0% up from last year.
  • As of Q3 2025, Cytek Biosciences' Return on Capital Employed stood at 0.08%, which was down 200.0% from 0.06% recorded in Q2 2025.
  • Cytek Biosciences' 5-year Return on Capital Employed high stood at 0.05% for Q3 2021, and its period low was 0.08% during Q3 2025.
  • In the last 5 years, Cytek Biosciences' Return on Capital Employed had a median value of 0.05% in 2024 and averaged 0.03%.
  • In the last 5 years, Cytek Biosciences' Return on Capital Employed plummeted by -600bps in 2023 and then surged by 100bps in 2024.
  • Quarter analysis of 5 years shows Cytek Biosciences' Return on Capital Employed stood at 0.02% in 2021, then plummeted by -118bps to 0.0% in 2022, then plummeted by -1477bps to 0.06% in 2023, then rose by 22bps to 0.05% in 2024, then crashed by -58bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.06% for Q2 2025, and 0.06% during Q1 2025.